Malaria: Central Africa can halve deaths by 2030
The MalaFA (Malaria Futures for Africa) study for Central Africa, commissioned by the Swiss pharmaceutical group Novartis, was presented Tuesday in Abuja, Nigeria. This study includes interviews with 23 politicians, senior officials, malaria program managers, researchers and NGOs in Cameroon, Democratic Republic of Congo (DRC), Republic of Congo and Rwanda. In these four...